Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Tang Capital Partners Lp
Relationship:   10% Owner
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   15    
Direct Shares   123,746    

Indirect Shares

   35,438,120      
Direct Value   $28,512    

Indirect Value

   $73,539,576      
Total Shares   35,561,866      
Total Value   $73,568,089      


Ardea Biosciences Inc $0 Heron Therapeutics Inc $25,682 Northstar Neuroscience Inc $0 Molecular Templates, Inc. $2,831 Aradigm Corp $0 Ardea Biosciences Inc $0 Heron Therapeutics Inc $25,682 Northstar Neuroscience Inc $0 Molecular Templates, Inc. $2,831 Aradigm Corp $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    14   
    1    

     Stock price went up :
    3   
    0    
     Stock price went down :
    11   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -4.3%
 -74.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Ardea Biosciences Inc RDEA 10% Owner 2012-02-01 15,089 2012-02-01 3,800,634    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 2018-09-12 6,941 2018-09-12 5,844,562    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 2008-02-15 0 2008-02-19 25,953    Premium*  
            Northstar Neuroscience Inc NSTR 10% Owner 2008-11-18 27,000 2008-11-18 3,706,926    Premium*  
            Neose Technologies Inc NTEC 10% Owner 0 2008-09-30 10,412,306    Premium*  
            Molecular Templates, Inc. MTEM 10% Owner 2008-08-29 4,716 2008-09-29 785,920    Premium*  
            Vanda Pharmaceuticals Inc. VNDA 10% Owner 0 2010-01-14 2,715,852    Premium*  
            Aradigm Corp ARDM 10% Owner 2008-10-21 70,000 2008-10-21 5,877,000    Premium*  
            Penwest Pharmaceuticals Co PPCO 10% Owner 2009-01-09 0 2010-09-20 0    Premium*  
            La Jolla Pharmaceutical Co LJPC 0 2014-07-23 1,699,067    Premium*  
            Cyclacel Pharmaceuticals Inc CYCC 10% Owner 0 2017-02-23 559,900    Premium*  
            Aptevo Therapeutics Inc. APVO Exit Filing 2020-11-04 0 2021-11-23 0    Premium*  
            Jounce Therapeutics Inc JNCE 10% Owner 2023-03-13 0 2023-05-03 10,000    Premium*  
            Tcr2 Therapeutics Inc. TCRR 10% Owner 2023-05-03 0 2023-06-01 0    Premium*  
            Rain Therapeutics Inc. RAIN 10% Owner 2023-05-30 0 2024-01-26 0    Premium*  
* Premium Members only  

Records found :    176         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
HRTX Heron Therapeutics Inc 10% Owner   –       –       •   2009-10-19 4 B $0.88 $2,149,999 I/I 2,443,181 10,436,506 1.5 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2011-01-20 4 B $26.00 $5,512,000 I/I 212,000 3,307,112 1.5 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2012-02-01 4 B $17.00 $7,249,990 I/I 426,470 3,733,582 1.5 -
HRTX Heron Therapeutics Inc 10% Owner   –       –       •   2014-06-25 4 B $11.75 $5,999,997 I/I 510,638 4,596,318 1.5 -
HRTX Heron Therapeutics Inc 10% Owner   –       –       •   2015-05-29 4 B $19.74 $2,274,058 I/I 115,225 4,711,543 1.5 -
HRTX Heron Therapeutics Inc 10% Owner   –       –       •   2015-06-01 4 B $19.30 $45,934 I/I 2,380 4,713,923 1.5 -
HRTX Heron Therapeutics Inc 10% Owner   –       –       •   2015-06-02 4 B $23.84 $772,294 I/I 32,395 4,746,318 1.5 -
HRTX Heron Therapeutics Inc 10% Owner   –       –       •   2015-06-10 4 B $24.75 $2,999,997 I/I 121,212 4,867,530 1.5 -
HRTX Heron Therapeutics Inc 10% Owner   –       –       •   2017-01-19 4 B $12.20 $29,999,995 I/I 2,459,016 8,332,907 1.5 -
CYCC Cyclacel Pharmaceuticals ... 10% Owner   –       –       •   2017-02-23 4 B $4.34 $582,079 I/I 134,200 559,900 1.5 -
HRTX Heron Therapeutics Inc 10% Owner   –       –       •   2018-03-29 4 B $26.00 $5,000,008 I/I 192,308 8,525,215 1.5 -
APVO Aptevo Therapeutics Inc. 10% Owner   –       –       •   2020-11-04 4 B $10.63 $9,137,026 I/I 636,675 960,000 1.5 %
APVO Aptevo Therapeutics Inc. 10% Owner   –       –       •   2020-11-05 4 B $14.22 $11,750,307 I/I 625,723 1,585,723 1.5 %
APVO Aptevo Therapeutics Inc. 10% Owner   –       –       •   2020-11-06 4 B $20.63 $3,961,898 I/I 174,277 1,760,000 1.5 %
JNCE Jounce Therapeutics Inc 10% Owner   –       –       •   2023-03-13 4 B $0.99 $65,307 I/I 65,701 5,279,801 1.5 %
JNCE Jounce Therapeutics Inc 10% Owner   –       –       •   2023-03-14 4 B $1.02 $20,651 I/I 20,286 5,300,087 1.5 %
TCRR Tcr2 Therapeutics Inc. 10% Owner   –       –       •   2023-05-03 4 B $1.85 $34,249 I/I 18,513 3,944,800 1.5 %
TCRR Tcr2 Therapeutics Inc. 10% Owner   –       –       •   2023-05-04 4 B $1.86 $193,888 I/I 104,241 4,049,041 1.5 %
TCRR Tcr2 Therapeutics Inc. 10% Owner   –       –       •   2023-05-05 4 B $1.90 $319,806 I/I 166,823 4,215,864 1.5 %
TCRR Tcr2 Therapeutics Inc. 10% Owner   –       –       •   2023-05-08 4 B $1.95 $111,292 I/I 57,073 4,272,937 1.5 %
TCRR Tcr2 Therapeutics Inc. 10% Owner   –       –       •   2023-05-09 4 B $1.95 $39,275 I/I 20,141 4,293,078 1.5 %
TCRR Tcr2 Therapeutics Inc. 10% Owner   –       –       •   2023-05-10 4 B $1.95 $13,209 I/I 6,774 4,299,852 1.5 %
TCRR Tcr2 Therapeutics Inc. 10% Owner   –       –       •   2023-05-11 4 B $1.95 $75,592 I/I 38,765 4,338,617 1.5 %
TCRR Tcr2 Therapeutics Inc. 10% Owner   –       –       •   2023-05-12 4 B $1.95 $12,057 I/I 6,183 4,344,800 1.5 %
TCRR Tcr2 Therapeutics Inc. 10% Owner   –       –       •   2023-05-25 4 B $1.72 $86,000 I/I 50,000 4,394,800 1.5 %
  176  Records found
  1   2   3   4   5  6   7   8      
  Page 5 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us